Precirix is currently owned by Jeito Capital, through Jeito I, since 2022.

When did Jeito Capital acquire Precirix?

Jeito Capital acquired Precirix in 2022 (active for 4 years).

Home/Companies/Biotech/Precirix

Precirix

Biotech·

Belgium·Active·4yr hold

Precirix is a healthcare company, headquartered in France.

Entry

2022

Hold

4yr

Status

Active

Est. EV

–

Investor

Jeito Capital

Key facts

HQFrance

SectorHealthcare

Brussels-based precision radiopharmaceuticals biotech developing antibody-targeted radiotherapies; Jeito Capital co-led EUR 80M Series B in…Read full notes

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

6 portfolio peers in Jeito I

6 comparable biotech deals from other GPs

Start free

Already a member? Sign in

Data refreshed weekly · Sourced from public filings